IGF-1, as the effector hormone of GH, mediates its protective role in the pathogenesis of NAFLD by regulating cholesterol transport and regulating the adipogenic pathway (43). The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.